Serum soluble interleukin-2 receptor levels in patients with breast cancer

Breast Cancer

Volumn 4, Issue 1, 1997, Pages 25-28

  Murakami, Saburo ^a   Hirayama, Rennzo ^a   Satomi, Akira ^a   Okubo, Katsuhiko ^a   Matsuki, Moriyoki ^a   Sakata, Hideto ^a   Tsuji, Yoshitaka ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; IL 2R; Tumor marker

Indexed keywords

EID: 0008816221     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967051     Document Type: Article

References (22)

1. Smith KA: Interleukin-2; Inception, impact, and implications. Science 240:1169-1176, 1988.
2. Berg JW, Hutter RVP: Breast cancer. Cancer 75:257-269, 1995.
3. Hayes DF, Sekine H, Ohno T, et al: Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest 75:1671-1678, 1985. (Pubitemid 15039493)
4. Hermanek P, Sobin LH eds: International Union Against Cancer; TNM Classification of Malignant Tumuors, 4th ed, Springer-Verlag, Germany, pp43-46, 1992.
5. Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording for Breast Cancer, 10th ed, Kanehara Shuppan, Tokyo, pp19-20, 1985.
6. Rubin LA, Kurman CC, Fritz ME, et al: Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3172-3177, 1985. (Pubitemid 16250575)
7. Rovelli F, Lissoni P, Crispino S, et al: Increased level of soluble interleukin-2 receptor in advanced solid tumors. Tumori 74:633-637, 1988. (Pubitemid 19068639)
8. Lissoni P, Barni S, Rovelli F, et al: The biological significance of soluble interleukin-2 receptor in solid tumors. Eur J Cancer 26:33-36, 1990. (Pubitemid 20121845)
9. Marino P, Cugno M, Preatoni A, et al: Increased levels of soluble interleukin-2 receptors in serum of patients cancer. Br J Cancer 61:434-435, 1990. (Pubitemid 20106021)
10. Yamaguchi K, Nishimura Y, Kiyokawa T, et al: Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma. J Lab Clin Med 116:457-461, 1990. (Pubitemid 20336613)
11. Pavlidis NS, Manoussakis MN, Germanidis GS, et al: Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies. Med Pediatric Oncol 20:26-31, 1992.
12. Ginns LS, Hoyos AD, Brown MC, et al: Elevated smokers concentration of soluble interleukin-2 receptors in serum of patients with lung cancer. Am Rev Respir Dis 142:398-402, 1990. (Pubitemid 20235952)
13. Honda M, Kitamura K, Matsuda K, et al: Soluble IL-2 receptors in AIDS. J Immunol 142:4248-4255, 1989.
14. Prummel MF, Wiersinga WM, Van der Gaag R, et al: Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. Clin Exp Immunol 88:405-409, 1992.
15. Pui CH, Ip SH, Iflah S, et al: Serum interleukin 2 receptor levels in childhood acute lymphoblastic leukemia. Blood 71:1135-1137, 1988.
16. Symons JA, Wood NC, Di Giovine FS, et al: Soluble IL-2 receptor in rheumatoid arthritis. J Immunol 141:2612-2618, 1988.
17. Tisi E, Lissoni P, Angeli M, et al: Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma. Cancer 69:2458-2462, 1992.
18. Keicho N, Kitamura K, Takaku F, et al: Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis. Chest 98:1125-1129, 1990. (Pubitemid 20381274)
19. Brown AE, Rieder KT, Wehster HK: Prolonged elevation of soluble interleukin-2 receptors in tuberculosis. Am Rev Respir Dis 139:1036-1038, 1989. (Pubitemid 19094335)
20. Murakami S, Satomi A, Ishida K, et al: Serum soluble interleukin-2 receptor in colorectal cancer. Acta Oncol 33:19-21, 1994. (Pubitemid 24131680)
21. Murakami S, Satomi A, Ishida K, et al: Serum soluble interleukin-2 receptor concentrations in patients with gastric cancer. Cancer 74:2745-2748, 1994. (Pubitemid 24340539)
22. Gotteland MG, May E, Levin FM, et al: Estrogen receptor (ER) in human breast cancer. Cancer 74:864-871, 1994.